Atrial fibrillation and acute coronary syndrome.
作者信息
Potpara Tatjana
机构信息
Medical Faculty, University of Belgrade, Belgrade, Serbia.
Cardiology Clinic, University Clinical Centre of Serbia, Belgrade, Serbia.
出版信息
EuroIntervention. 2024 Aug 19;20(16):961-3. doi: 10.4244/EIJ-E-24-00043.
Abstract
摘要
相似文献
1
Atrial fibrillation and acute coronary syndrome.心房颤动与急性冠状动脉综合征。
EuroIntervention. 2024 Aug 19;20(16):961-3. doi: 10.4244/EIJ-E-24-00043.
2
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.急性冠状动脉综合征或经皮冠状动脉介入治疗后早期和晚期心房颤动患者抗栓治疗的风险/获益权衡：来自 AUGUSTUS 的见解。
Circulation. 2020 May 19;141(20):1618-1627. doi: 10.1161/CIRCULATIONAHA.120.046534. Epub 2020 Mar 29.
3
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial.根据 ACS 和 PCI 后时间，口服抗凝治疗的房颤患者双联与单联抗血小板治疗的相对获益：AUGUSTUS 试验的结果。
Circ Cardiovasc Interv. 2024 Nov;17(11):e013596. doi: 10.1161/CIRCINTERVENTIONS.123.013596. Epub 2024 Nov 6.
4
Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study.冠状动脉搭桥手术和经皮冠状动脉介入治疗后房颤的发生率：前瞻性AFAF队列研究
Scand Cardiovasc J. 2024 Dec;58(1):2347297. doi: 10.1080/14017431.2024.2347297. Epub 2024 May 2.
5
The impact of atrial fibrillation type on clinical outcomes and antithrombotic therapy at discharge in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a real-world study.急性冠状动脉综合征患者或接受经皮冠状动脉介入治疗患者的房颤类型对临床结局及出院时抗栓治疗的影响：一项真实世界研究
BMC Cardiovasc Disord. 2025 Aug 2;25(1):570. doi: 10.1186/s12872-025-05042-7.
6
Dual Versus Triple Antithrombotic Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: An Updated Meta-Analysis.急性冠状动脉综合征或经皮冠状动脉介入治疗后房颤患者的双联与三联抗栓治疗：一项更新的荟萃分析
Cardiovasc Revasc Med. 2020 Feb;21(2):239-241. doi: 10.1016/j.carrev.2019.08.015. Epub 2019 Aug 20.
7
Atrial fibrillation and coronary stenting: is the AUGUSTUS trial the end of triple therapy?心房颤动与冠状动脉支架置入术：AUGUSTUS试验会终结三联疗法吗？
Future Cardiol. 2019 Sep;15(5):319-321. doi: 10.2217/fca-2019-0027. Epub 2019 Aug 6.
8
Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting.用于房颤以及有或无支架置入的急性冠状动脉综合征的口服抗凝药。
J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e40-e45. doi: 10.2459/JCM.0000000000000597.
9
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome undergoing percutaneous coronary intervention; insights from a meta-analysis.抗栓治疗在经皮冠状动脉介入治疗的心房颤动合并急性冠状动脉综合征患者中的应用：一项荟萃分析的见解。
Coron Artery Dis. 2021 Jan;32(1):31-35. doi: 10.1097/MCA.0000000000000900.
10
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis.急性冠脉综合征中的新发或既往存在的心房颤动：两种不同现象，预后相似。
Rev Esp Cardiol (Engl Ed). 2019 May;72(5):383-391. doi: 10.1016/j.rec.2018.03.002. Epub 2018 Apr 10.
引用本文的文献
1
The impact of atrial fibrillation type on clinical outcomes and antithrombotic therapy at discharge in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a real-world study.急性冠状动脉综合征患者或接受经皮冠状动脉介入治疗患者的房颤类型对临床结局及出院时抗栓治疗的影响：一项真实世界研究
BMC Cardiovasc Disord. 2025 Aug 2;25(1):570. doi: 10.1186/s12872-025-05042-7.
本文引用的文献
1
Bidirectional Association Between Atrial Fibrillation and Myocardial Infarction, and Relation to Mortality in the Framingham Heart Study.心房颤动与心肌梗死的双向关联，及其与弗雷明汉心脏研究死亡率的关系。
J Am Heart Assoc. 2024 Jun 4;13(11):e032226. doi: 10.1161/JAHA.123.032226. Epub 2024 May 23.
2
Atrial fibrillation: stroke prevention.心房颤动：预防中风。
Lancet Reg Health Eur. 2024 Feb 1;37:100797. doi: 10.1016/j.lanepe.2023.100797. eCollection 2024 Feb.
3
Temporal Relation Between Myocardial Infarction and New-Onset Atrial Fibrillation: Results from a Nationwide Registry Study.心肌梗死与新发心房颤动之间的时间关系：一项全国性登记研究的结果
Am J Cardiol. 2024 Jan 15;211:49-56. doi: 10.1016/j.amjcard.2023.10.071. Epub 2023 Nov 3.
4
Atrial fibrillation: villain or bystander in vascular brain injury.心房颤动：血管性脑损伤中的“反派”还是“旁观者”？
Eur Heart J Suppl. 2020 Dec 6;22(Suppl M):M51-M59. doi: 10.1093/eurheartj/suaa166. eCollection 2020 Nov.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
Zotero 插件